Troy Edward Wilson - 02 Jan 2025 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KURA	Option to purchase common stock	Award	$0	+625,000		$0.000000	625,000	02 Jan 2025	Common Stock	625,000	$8.68	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This option vests in 48 equal monthly installments commencing on the grant date.